![John Richards](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John Richards
Presidente presso AKTIENBRAUEREI KAUFBEUREN AG
Patrimonio netto: - $ in data 30/06/2024
Posizioni attive di John Richards
Società | Posizione | Inizio | Fine |
---|---|---|---|
AKTIENBRAUEREI KAUFBEUREN AG | Presidente | 30/09/2022 | - |
Direttore/Membro del Consiglio | 10/02/2022 | 30/09/2022 | |
Comanche Biopharma Corp.
![]() Comanche Biopharma Corp. Miscellaneous Commercial ServicesCommercial Services Comanche Biopharma Corp. is a maternal and fetal medicine biopharmaceutical company based in Concord, MA. The company is working to lower the risks of pregnancy and premature births worldwide by developing the world's first treatment for preeclampsia, which affects more than 10 million women every year. Comanche Biopharma's founders have had successful careers discovering new medicines, building and selling companies, and taking on some of the hardest challenges in medicine. Comanche Biopharma is committed to the ethical representation of people of all colors and economic status in their clinical development programs and prioritizes ensuring access to their solutions by those who need them most. The company was founded by Michael Young, and the CEO is T. Scott Johnson. | Corporate Officer/Principal | - | - |
Storia della carriera di John Richards
Precedenti posizioni note di John Richards
Società | Posizione | Inizio | Fine |
---|---|---|---|
APTAMER GROUP PLC | Direttore/Membro del Consiglio | - | 21/08/2023 |
PANACOS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/02/2006 | 13/02/2009 |
ImmuLogic Pharmaceutical Corp.
![]() ImmuLogic Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology ImmuLogic Pharmaceutical Corporation is a biopharmaceutical company. The company focuses on the research and clinical development of products to treat allergies, autoimmune diseases, and vaccines for the management of drugs of abuse. It was founded on March 26, 1987 and is headquartered in Woburn, MN. | Corporate Officer/Principal | 01/01/1993 | 01/10/1997 |
Zeneca Group Plc
![]() Zeneca Group Plc Pharmaceuticals: MajorHealth Technology Zeneca Group Plc used to develop & manufacture pharmaceutical products, agrochemicals and specialties chemicals. Its agrochemicals products include herbicides, insecticides and fungicides. The firm products were used by health care, agrochemical, paint, leather and imaging applications industries. The company was headquartered in London, UK. | Direttore Tecnico/Scientifico/R&S | 01/01/1989 | 01/01/1993 |
Novartis Pharmaceuticals Corp.
![]() Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | - | - |
THE MEDICINES COMPANY | Corporate Officer/Principal | 01/10/1997 | - |
Formazione di John Richards
University of Oxford | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 6 |
Regno Unito | 4 |
Germania | 2 |
Posizioni
Corporate Officer/Principal | 5 |
Director/Board Member | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Settori
Health Technology | 7 |
Consumer Services | 2 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 3 |
---|---|
PANACOS PHARMACEUTICALS, INC. | Health Technology |
APTAMER GROUP PLC | Health Technology |
AKTIENBRAUEREI KAUFBEUREN AG | Finance |
Aziende private | 5 |
---|---|
The Medicines Co.
![]() The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
ImmuLogic Pharmaceutical Corp.
![]() ImmuLogic Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology ImmuLogic Pharmaceutical Corporation is a biopharmaceutical company. The company focuses on the research and clinical development of products to treat allergies, autoimmune diseases, and vaccines for the management of drugs of abuse. It was founded on March 26, 1987 and is headquartered in Woburn, MN. | Health Technology |
Zeneca Group Plc
![]() Zeneca Group Plc Pharmaceuticals: MajorHealth Technology Zeneca Group Plc used to develop & manufacture pharmaceutical products, agrochemicals and specialties chemicals. Its agrochemicals products include herbicides, insecticides and fungicides. The firm products were used by health care, agrochemical, paint, leather and imaging applications industries. The company was headquartered in London, UK. | Health Technology |
Novartis Pharmaceuticals Corp.
![]() Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
Comanche Biopharma Corp.
![]() Comanche Biopharma Corp. Miscellaneous Commercial ServicesCommercial Services Comanche Biopharma Corp. is a maternal and fetal medicine biopharmaceutical company based in Concord, MA. The company is working to lower the risks of pregnancy and premature births worldwide by developing the world's first treatment for preeclampsia, which affects more than 10 million women every year. Comanche Biopharma's founders have had successful careers discovering new medicines, building and selling companies, and taking on some of the hardest challenges in medicine. Comanche Biopharma is committed to the ethical representation of people of all colors and economic status in their clinical development programs and prioritizes ensuring access to their solutions by those who need them most. The company was founded by Michael Young, and the CEO is T. Scott Johnson. | Commercial Services |
- Borsa valori
- Insiders
- John Richards
- Esperienza